Ronald Reed, MD - Medicare Emergency Medicine in West Reading, PA

Ronald Reed, MD is a medicare enrolled "Emergency Medicine" physician in West Reading, Pennsylvania. His current practice location is 420 S 5th Ave, West Reading, Pennsylvania. You can reach out to his office (for appointments etc.) via phone at (484) 628-3637.

Ronald Reed is licensed to practice in Pennsylvania (license number MD014550E) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1346290483.

Contact Information

Ronald Reed, MD
420 S 5th Ave,
West Reading, PA 19611
(484) 628-3637
Not Available



Physician's Profile

Full NameRonald Reed
GenderMale
SpecialityEmergency Medicine
Location420 S 5th Ave, West Reading, Pennsylvania
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1346290483
  • Provider Enumeration Date: 05/11/2006
  • Last Update Date: 05/30/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 1052596277
  • Enrollment ID: I20110503000098

Medical Identifiers

Medical identifiers for Ronald Reed such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1346290483NPI-NPPES
000645785MedicaidPA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine MD014550E (Pennsylvania)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Ronald Reed allows following entities to bill medicare on his behalf.
Entity NameTower Health Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1609291350
PECOS PAC ID: 7618889213
Enrollment ID: O20040311000072

News Archive

Protox decreases third quarter net and comprehensive loss to $1.6 million

Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today released financial results for the third quarter, ended September 30, 2010.

BAC adds affinity resin for AAT purification to GE Healthcare's range of custom designed media

BAC BV, the leading provider of antibody-based affinity purification technology, has extended its collaboration with GE Healthcare with the addition of a new bioprocess affinity chromatography ligand to GE Healthcare's range of custom designed media. The latest addition to the range is an affinity resin for the purification of alpha-1 antitrypsin (AAT) from blood plasma, recombinant cell culture or transgenic sources. The new resin has been developed as part of GE Healthcare's Custom Designed Media (CDM) programme and provides a new solution for AAT purification in the biopharmaceutical industry.

UT Southwestern researchers find cause and way to prevent vision deterioration in astronauts

Vision deterioration in astronauts who spend a long time in space is likely due to the lack of a day-night cycle in intracranial pressure. But using a vacuum device to lower pressure for part of each day might prevent the problem, UT Southwestern Medical Center researchers said. Their study appears in the Journal of Physiology.

Combination of perifosine and temsirolimus shows promise against malignant glioma

Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").

Read more Medical News

› Verified 7 days ago

Entity NameReading Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1992387518
PECOS PAC ID: 7618886490
Enrollment ID: O20040408001076

News Archive

Protox decreases third quarter net and comprehensive loss to $1.6 million

Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today released financial results for the third quarter, ended September 30, 2010.

BAC adds affinity resin for AAT purification to GE Healthcare's range of custom designed media

BAC BV, the leading provider of antibody-based affinity purification technology, has extended its collaboration with GE Healthcare with the addition of a new bioprocess affinity chromatography ligand to GE Healthcare's range of custom designed media. The latest addition to the range is an affinity resin for the purification of alpha-1 antitrypsin (AAT) from blood plasma, recombinant cell culture or transgenic sources. The new resin has been developed as part of GE Healthcare's Custom Designed Media (CDM) programme and provides a new solution for AAT purification in the biopharmaceutical industry.

UT Southwestern researchers find cause and way to prevent vision deterioration in astronauts

Vision deterioration in astronauts who spend a long time in space is likely due to the lack of a day-night cycle in intracranial pressure. But using a vacuum device to lower pressure for part of each day might prevent the problem, UT Southwestern Medical Center researchers said. Their study appears in the Journal of Physiology.

Combination of perifosine and temsirolimus shows promise against malignant glioma

Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ronald Reed is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Ronald Reed, MD
Po Box 13579,
Reading, PA 19612-3579

Ph: (484) 628-0799
Ronald Reed, MD
420 S 5th Ave,
West Reading, PA 19611

Ph: (484) 628-3637

News Archive

Protox decreases third quarter net and comprehensive loss to $1.6 million

Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today released financial results for the third quarter, ended September 30, 2010.

BAC adds affinity resin for AAT purification to GE Healthcare's range of custom designed media

BAC BV, the leading provider of antibody-based affinity purification technology, has extended its collaboration with GE Healthcare with the addition of a new bioprocess affinity chromatography ligand to GE Healthcare's range of custom designed media. The latest addition to the range is an affinity resin for the purification of alpha-1 antitrypsin (AAT) from blood plasma, recombinant cell culture or transgenic sources. The new resin has been developed as part of GE Healthcare's Custom Designed Media (CDM) programme and provides a new solution for AAT purification in the biopharmaceutical industry.

UT Southwestern researchers find cause and way to prevent vision deterioration in astronauts

Vision deterioration in astronauts who spend a long time in space is likely due to the lack of a day-night cycle in intracranial pressure. But using a vacuum device to lower pressure for part of each day might prevent the problem, UT Southwestern Medical Center researchers said. Their study appears in the Journal of Physiology.

Combination of perifosine and temsirolimus shows promise against malignant glioma

Aeterna Zentaris Inc. today announced that perifosine, its oral AKT inhibitor, combined with temsirolimus ("TEM"), was well tolerated in an investigator driven Phase 1 clinical trial in recurrent or progressive malignant glioma ("MG").

Read more News

› Verified 7 days ago


Emergency Medicine Doctors in West Reading, PA

Liza Gergenti, MD
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 420 S 5th Ave, West Reading, PA 19611
Phone: 484-628-3528    
Joshua Adam Werner, DO
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 420 S 5th Ave, West Reading, PA 19611
Phone: 484-628-3637    
Eric Smith, DO
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 420 S 5th Ave, West Reading, PA 19611
Phone: 484-628-8000    
James Sullivan, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 420 S 5th Ave, West Reading, PA 19611
Phone: 484-628-8000    
Ray Morganti, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 6th Ave & Spruce St, West Reading, PA 19611
Phone: 610-988-8218    
Dr. Joseph Patrick Corcoran Iv, MD
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 420 S 5th Ave, West Reading, PA 19611
Phone: 484-628-8000    
Memu-iye Kamara, DO
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 420 S 5th Ave, West Reading, PA 19611
Phone: 484-628-8000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.